Showing 5,171 results

Filters Content type: Editors' picks Country: United States
New & experimental hepatitis C treatment

Fair Pricing Coalition Recognizes Merck’s Lower Price for Curative Hepatitis C Treatment, Calls for Manufacturers to Reduce Excessive Prices and Increase Patient Assistance

Editor's pick
Fair Pricing Coalition
8 February 2016
New & experimental hepatitis C treatment

U.S. FDA Approves Expanded Use of Bristol-Myers Squibb’s Daklinza (daclatasvir) for Additional Challenging-to-treat Patients with Genotype 1 or Genotype 3 Chronic Hepatitis C

Editor's pick
Bristol-Myers Squibb press release
8 February 2016
HIV & criminal law

HIV Criminalization Laws Disproportionately Punish People of Color

Editor's pick
BETA blog
5 February 2016
Hepatitis C treatment

Pennsylvania to Offer Free Hepatitis C Treatment to Low-Income People With HIV

Editor's pick
Poz magazine news
5 February 2016
Access to healthcare

CDC: Blacks with HIV less likely to receive consistent medical care

Editor's pick
Atlanta Journal Constitution
5 February 2016
Economic & social inequality

US: Study shows direct link between state spending habits and AIDS deaths

Editor's pick
Eurekalert Inf Dis
4 February 2016
Activism & civil society

Lawsuits claim insurers unfairly refuse pricey hepatitis C drugs

Editor's pick
Seattle Times
3 February 2016
Hepatitis C treatment

Lawmaker: Costly hepatitis C drug "a slap in the face to veterans"

Editor's pick
CBS News
3 February 2016
Harm reduction

President Obama seeks $1.1 billion to fight heroin and opiate epidemic

Editor's pick
The Independent
3 February 2016
Sexually transmitted infections epidemiology

Zika Infection Transmitted by Sex Reported in Texas

Editor's pick
New York Times
3 February 2016
Activism & civil society

High-level meeting on HIV/AIDS – how to get involved

Editor's pick
ICASO
2 February 2016
Access to healthcare

Pfizer attempts to mislead public over research and development ‘facts’ with Tube ads

Editor's pick
MSF Access Campaign
2 February 2016
Pharmaceutical industry

Merck Throws a Wrench in Drug Pricing

Editor's pick
Bloomberg
1 February 2016
Sex workers

Examining the Implications of PrEP as HIV Prevention for Sex Workers

Editor's pick
Institute of Development Studies
1 February 2016
Treatment guidelines

US: Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Editor's pick
AIDS.info
1 February 2016
Government, leadership & policy

Only 3 Presidential Candidates Share How They Will Address HIV

Editor's pick
HIVPlus
1 February 2016
Dating, relationships & feelings

How to Talk to Your Partner About Going on PrEP

Editor's pick
HIV Plus
1 February 2016
PrEP

We Aren’t the Sex Police: What PrEP Providers Say About Condoms & STIs

Editor's pick
BETA blog
30 January 2016
Hepatitis C treatment

Merck Prices Hepatitis C Drug Lower Than Rivals in Crowded Field

Editor's pick
Bloomberg
29 January 2016
New & experimental hepatitis C treatment

Merck Receives FDA Approval of ZEPATIER™ (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults

Editor's pick
Merck press release
29 January 2016
Hepatitis C transmission & prevention

HCV on the Rise in Dialysis Patients, CDC Warns

Editor's pick
MedPage Today HIV/AIDS
29 January 2016
Hepatitis C treatment

California Doles Out Millions to Insurers for Hepatitis C Drugs

Editor's pick
KQED News
29 January 2016
Pharmaceutical industry

Gilead Faces Fights Over Hepatitis C and H.I.V. Drugs

Editor's pick
New York Times
28 January 2016
The search for a cure

HIV protein manipulates hundreds of human genes to advance progression into AIDS, study shows

Editor's pick
UT Southwestern Medical Center
28 January 2016